Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Immunogenic myositis].

D Pongratz1

  • 1Friedrich-Baur-Institut der Medizinischen Fakultät an der Neurologischen Klinik und Poliklinik der Ludwig Maximilians Universität München. dieter.pongratz@med.uni-muenchen.de

Deutsche Medizinische Wochenschrift (1946)
|February 10, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

LGMD 2I due to the common mutation 826C>A in the FKRP gene presenting as myopathy with vacuoles and paired-helical filaments.

Acta myologica : myopathies and cardiomyopathies : official journal of the Mediterranean Society of Myology·2008
Same author

Adult-onset glycogen storage disease type 2: clinico-pathological phenotype revisited.

Neuropathology and applied neurobiology·2007
Same author

Serum levels of matrix metalloproteinases-2 and -9 and their tissue inhibitors in inflammatory neuromuscular disorders.

European neurology·2006
Same author

Milling precision and fitting accuracy of Cerec Scan milled restorations.

International journal of computerized dentistry·2006
Same author

Prediction of response to IVIg treatment in patients with lower motor neurone disorders.

European journal of neurology·2006
Same author

[A randomized, double blind, placebo-controlled study of the efficacy and safety of tolperisone in spasticity following cerebral stroke].

Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova·2006
Same journal

Deutsche medizinische Wochenschrift (1946)·2026
Same journal

["Not everything that looks like a tumor..." - Pulmonary tularemia with hilar lymphadenopathy].

Deutsche medizinische Wochenschrift (1946)·2026
Same journal

[Emergency management of sickle cell disease].

Deutsche medizinische Wochenschrift (1946)·2026
Same journal

[Hereditary dehydrated stomatocytosis (= hereditary xerocytosis) - Interesting hummingbird or clinically relevant diagnosis?]

Deutsche medizinische Wochenschrift (1946)·2026
Same journal

[Diagnosis of Congenital Hemolytic Anemias in Adults].

Deutsche medizinische Wochenschrift (1946)·2026
Same journal

[46-year-old female patient with right upper abdominal pain].

Deutsche medizinische Wochenschrift (1946)·2026
See all related articles

Immunogenic inflammatory myopathies are acquired muscle disorders characterized by weakness and inflammation. Corticosteroids and immunosuppressives are primary treatments, with intravenous immunoglobulin (IVIG) useful for inclusion body myositis.

Area of Science:

  • Neurology
  • Rheumatology
  • Immunology

Background:

  • Inflammatory myopathies are a diverse set of acquired muscle diseases.
  • Characterized by muscle weakness and inflammatory cell infiltration in muscle tissue.

Observation:

  • Three primary groups with distinct pathogenesis and clinical courses exist.
  • Clinical presentation includes progressive muscle weakness.

Findings:

  • Treatment relies heavily on empirical data.
  • Corticosteroids and immunosuppressants form the baseline therapy.
  • High-dose intravenous immunoglobulin (IVIG) offers an additional therapeutic option, particularly for inclusion body myositis.

Implications:

  • Understanding the heterogeneity of inflammatory myopathies is crucial for targeted treatment.

Related Experiment Videos

  • IVIG represents a valuable adjunctive therapy for specific subtypes like inclusion body myositis.
  • Further research into pathogenesis may refine treatment strategies for these debilitating muscle disorders.